AARTI DRUGS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 499.4 INR | +1.32% |
|
+5.10% | +2.12% |
| May. 06 | Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024 | |
| May. 03 | Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Aarti Drugs Limited
Price target over the last 5 years
History of analyst recommendation changes
ca0.Qh7Kif687SsHi_MeNsMbdwv2aD6YW1t0X_msM5OPGaU.eiyN4b_1vRtg4YcqeawvH3q8KVWsLG8ROoGZeNv7b-cDbP_DtITZZES5nA~719727a60955f01698a5e3b1e5c52787
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
492.9
INR
Average target price
542
INR
Spread / Average Target
+9.96%
High Price Target
542
INR
Spread / Highest target
+9.96%
Low Price Target
542
INR
Spread / Lowest Target
+9.96%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AARTIDRUGS Stock
- Consensus Aarti Drugs Limited
